Jones RL - Search Results

1

The proteomic landscape of soft tissue sarcomas.

Burns J, Wilding CP, Krasny L, Zhu X, Chadha M, Tam YB, Ps H, Mahalingam AH, Lee ATJ, Arthur A, Guljar N, Perkins E, Pankova V, Jenks A, Djabatey V, Szecsei C, McCarthy F, Ragulan C, Milighetti M, Roumeliotis TI, Crosier S, Finetti M, Choudhary JS, Judson I, Fisher C, Schuster EF, Sadanandam A, Chen TW, Williamson D, Thway K, Jones RL, Cheang MCU, Huang PH. Burns J, et al. Among authors: jones rl. Nat Commun. 2023 Jun 29;14(1):3834. doi: 10.1038/s41467-023-39486-2. Nat Commun. 2023. PMID: 37386008 Free PMC article.

2

The development and application of imatinib.

Jones RL, Judson IR. Jones RL, et al. Expert Opin Drug Saf. 2005 Mar;4(2):183-91. doi: 10.1517/14740338.4.2.183. Expert Opin Drug Saf. 2005. PMID: 15794712 Review.

3

Differential sensitivity of liposarcoma subtypes to chemotherapy.

Jones RL, Fisher C, Al-Muderis O, Judson IR. Jones RL, et al. Eur J Cancer. 2005 Dec;41(18):2853-60. doi: 10.1016/j.ejca.2005.07.023. Epub 2005 Nov 10. Eur J Cancer. 2005. PMID: 16289617

4

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.

Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Constantinidou A, et al. Among authors: jones rl. Eur J Cancer. 2009 Nov;45(17):2930-4. doi: 10.1016/j.ejca.2009.08.016. Epub 2009 Sep 18. Eur J Cancer. 2009. PMID: 19767198 Clinical Trial.

5

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma.

Jones RL, McCall J, Adam A, O'Donnell D, Ashley S, Al-Muderis O, Thway K, Fisher C, Judson IR. Jones RL, et al. Eur J Surg Oncol. 2010 May;36(5):477-82. doi: 10.1016/j.ejso.2009.12.005. Epub 2010 Jan 8. Eur J Surg Oncol. 2010. PMID: 20060679

6

Chemotherapy in clear cell sarcoma.

Jones RL, Constantinidou A, Thway K, Ashley S, Scurr M, Al-Muderis O, Fisher C, Antonescu CR, D'Adamo DR, Keohan ML, Maki RG, Judson IR. Jones RL, et al. Med Oncol. 2011 Sep;28(3):859-63. doi: 10.1007/s12032-010-9502-7. Med Oncol. 2011. PMID: 20390470

7

Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.

Minchom A, Jones RL, Fisher C, Al-Muderis O, Ashley S, Scurr M, Karavasilis V, Judson IR. Minchom A, et al. Among authors: jones rl. Sarcoma. 2010;2010:264360. doi: 10.1155/2010/264360. Epub 2010 May 20. Sarcoma. 2010. PMID: 20508840 Free PMC article.

8

Atypical metastatic profile in Stewart-Treves syndrome.

Almond MH, Jones RL, Thway K, Fisher C, Moskovic E, Judson IR. Almond MH, et al. Among authors: jones rl. Acta Oncol. 2010 Nov;49(8):1388-90. doi: 10.3109/0284186X.2010.491089. Epub 2010 Jun 4. Acta Oncol. 2010. PMID: 20524777 No abstract available.

9

Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside.

Olmos D, Tan DS, Jones RL, Judson IR. Olmos D, et al. Among authors: jones rl. Cancer J. 2010 May-Jun;16(3):183-94. doi: 10.1097/PPO.0b013e3181dbebf9. Cancer J. 2010. PMID: 20526094 Review.

10

Fungal spinal cord compression in metastatic synovial sarcoma.

Ratnayake G, Judson IR, Scurr M, Thway K, Fisher C, Jones RL. Ratnayake G, et al. Among authors: jones rl. Acta Oncol. 2011 Jan;50(1):158-9. doi: 10.3109/0284186X.2010.498830. Epub 2010 Aug 20. Acta Oncol. 2011. PMID: 20726686 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,355 results

Search Page